David Hart

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans et al. · JAMA · 2023 · 2.6K citations · Full text

Medicine, Neurology, Neuroscience +17

Artificial stone-associated silicosis: a rapidly emerging occupational lung disease

Ryan Hoy, Timothy Baird, Gary Hammerschlag et al. · Occupational and Environmental Medicine · 2017 · 191 citations · Full text

Medicine, Clinical Sciences, Radiology +10

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease

Edmond Teng, Paul T. Manser, Karen Pickthorn et al. · JAMA Neurology · 2022 · 191 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment

Chenzhong Yin, Phoebe Imms, Mingxi Cheng et al. · Proceedings of the National Academy of Sciences · 2023 · 120 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis

Xiaopu Zhou, Yu Chen, Kin Y. Mok et al. · Proceedings of the National Academy of Sciences · 2018 · 103 citations · Full text

Life Sciences, Genetics, Immunology +17